These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 24473363)
1. Alcoholic hepatitis: potential role of cytokine CCL20 in alcoholic hepatitis. Leake I Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):76. PubMed ID: 24473363 [No Abstract] [Full Text] [Related]
2. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p. Hanson A; Piras IS; Wilhelmsen D; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK Cytokine; 2019 Nov; 123():154789. PubMed ID: 31352173 [TBL] [Abstract][Full Text] [Related]
3. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Affò S; Morales-Ibanez O; Rodrigo-Torres D; Altamirano J; Blaya D; Dapito DH; Millán C; Coll M; Caviglia JM; Arroyo V; Caballería J; Schwabe RF; Ginès P; Bataller R; Sancho-Bru P Gut; 2014 Nov; 63(11):1782-92. PubMed ID: 24415562 [TBL] [Abstract][Full Text] [Related]
4. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218 [TBL] [Abstract][Full Text] [Related]
5. The interleukin-17 pathway is involved in human alcoholic liver disease. Lemmers A; Moreno C; Gustot T; Maréchal R; Degré D; Demetter P; de Nadai P; Geerts A; Quertinmont E; Vercruysse V; Le Moine O; Devière J Hepatology; 2009 Feb; 49(2):646-57. PubMed ID: 19177575 [TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. Afford SC; Fisher NC; Neil DA; Fear J; Brun P; Hubscher SG; Adams DH J Pathol; 1998 Sep; 186(1):82-9. PubMed ID: 9875144 [TBL] [Abstract][Full Text] [Related]
7. TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression. Iwamoto S; Kido M; Aoki N; Nishiura H; Maruoka R; Ikeda A; Okazaki T; Chiba T; Watanabe N Clin Immunol; 2013 Jan; 146(1):15-25. PubMed ID: 23178752 [TBL] [Abstract][Full Text] [Related]
8. Immunologic abnormalities in alcoholic liver disease. Scheig R Am J Gastroenterol; 1990 Apr; 85(4):371. PubMed ID: 2327376 [No Abstract] [Full Text] [Related]
18. [Effect of alcohol on the lipid spectrum of the blood serum in patients with chronic persistent hepatitis]. Makarov VK Vrach Delo; 1983 Mar; (3):45-7. PubMed ID: 6858101 [No Abstract] [Full Text] [Related]
19. Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Hines IN; Wheeler MD Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G310-4. PubMed ID: 15246965 [TBL] [Abstract][Full Text] [Related]
20. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. Hill DB; Marsano L; Cohen D; Allen J; Shedlofsky S; McClain CJ J Lab Clin Med; 1992 May; 119(5):547-52. PubMed ID: 1583411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]